Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro Diagnostics

PUBLISHER: Grand View Research | PRODUCT CODE: 1986393

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1986393

Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests, Dilution And Concentration Tests), By End Use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Kidney Function Tests Market Summary

The global kidney function tests market size was valued at USD 1.12 billion in 2025 and is projected to reach USD 1.77 billion by 2033, growing at a CAGR of 5.87% from 2026 to 2033. Several factors are anticipated to drive market growth, including increased investments by industry players, growing research and development efforts, a high prevalence of renal diseases, government initiatives, and advancements in technology.

For instance, in February 2024, Simple HealthKit launched a new renal evaluation test for diabetes. The test is available for clinics and at home settings. Such developments are likely to propel the growth of kidney function tests industry.

During the COVID-19 pandemic, the incidence of renal injury increased significantly. Research highlighted that the individuals with pre-existing renal conditions faced a higher risk of severe complications and poorer outcomes upon contracting COVID-19. Ongoing studies on the long-term effects of COVID-19 have also revealed its potential lasting impact on renal health. However, the pandemic disrupted healthcare services for renal disease patients, as lockdowns and social distancing mandates led to temporary closures of non-emergency medical services. This resulted in delays in diagnosing renal diseases due to the suspension of routine visits and diagnostic tests during peak pandemic phases.

The rising prevalence of acute kidney injury (AKI) and its progression to CKD is expected to propel the kidney function tests industry in the forecast period. CKD refers to persistent structural and functional abnormalities in the kidneys lasting at least three months. Conditions such as lifestyle-related diseases and kidney injuries are major contributors to CKD, which remains a global health burden and a leading cause of morbidity and mortality worldwide. According to the World Health Organization (WHO), renal disease has risen to become one of the top 10 leading causes of death globally over the past decade. Additionally, the National Kidney Foundation reports that approximately 37 million people in the U.S., or over one in seven adults, are affected by some form of renal disease.

Global Kidney Function Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global kidney function tests on the basis of product, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Clearance Tests
  • Urine Tests
  • Blood Tests
  • Dilution And Concentration Tests
  • Other Tests
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Research Laboratories and Institutes
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Thailand
    • South Korea
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-1-68038-721-6

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End use
    • 1.2.3. Application
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Kidney Function Tests Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Introduction Of Innovative Kidney Function Tests
      • 3.2.1.2. Increasing Investments In R&D
      • 3.2.1.3. Increasing Prevalence of Acute Kidney Injury And Associated Chronic Kidney Disease
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low Awareness Regarding Kidney Diseases
  • 3.3. Kidney Function Tests Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Kidney Function Tests Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2025 & 2033
  • 4.2. Segment Dashboard
  • 4.3. Global Kidney Function Tests Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 4.4.1. Clearance Tests
      • 4.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
    • 4.4.2. Blood Tests
      • 4.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.3. Urine Tests
      • 4.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.4. Dilution & Concentration Tests
      • 4.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.4.5. Other Tests
      • 4.4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Kidney Function Tests Market: End Use Estimates & Trend Analysis

  • 5.1. End Use Market Share, 2025 & 2033
  • 5.2. Segment Dashboard
  • 5.3. Global Kidney Function Tests Market by End Use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
    • 5.4.2. Diagnostic Laboratories
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Research Laboratories And Institutes
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Kidney Function Tests Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2025 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company market share analysis, 2025
    • 7.3.2. Abbott
      • 7.3.2.1. Company overview
      • 7.3.2.2. Financial performance
      • 7.3.2.3. Product benchmarking
      • 7.3.2.4. Strategic initiatives
    • 7.3.3. Danaher
      • 7.3.3.1. Company overview
      • 7.3.3.2. Financial performance
      • 7.3.3.3. Product benchmarking
      • 7.3.3.4. Strategic initiatives
    • 7.3.4. F. Hoffmann-La Roche Ltd
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Sysmex Corporation
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Siemens Healthineers
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Randox Laboratories Ltd
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Quest Diagnostics
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Acon Laboratories, Inc
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. Nova Biomedical Corporation
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Laboratory Corporation Of America Holdings
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
Show more
Product Code: GVR-1-68038-721-6

List of Tables

  • Table 1 Premarket approval process
  • Table 2 Key companies adopting expansion strategy
  • Table 3 Key companies adopting collaboration strategy
  • Table 4 Key companies launching new products/services
  • Table 5 Key companies adopting partnership strategy
  • Table 6 List of Secondary Sources
  • Table 7 List of Abbreviations
  • Table 8 Global Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 9 Global Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 10 Global Kidney Function Tests Market, by Region, 2021 - 2033 (USD Million)
  • Table 11 North America Kidney Function Tests Market, by Country, 2021 - 2033 (USD Million)
  • Table 12 North America Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 13 North America Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 14 U.S. Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 15 U.S. Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16 Canada Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 17 Canada Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 18 Mexico Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 19 Mexico Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20 Europe Kidney Function Tests Market, by Country, 2021 - 2033 (USD Million)
  • Table 21 Europe Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 22 Europe Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 23 Germany Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 24 Germany Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 25 UK Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 26 UK Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 27 France Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 28 France Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29 Italy Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 30 Italy Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 31 Spain Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 32 Spain Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33 Denmark Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 34 Denmark Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 35 Sweden Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 36 Sweden Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 37 Norway Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 38 Norway Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 39 Asia Pacific Kidney Function Tests Market, by Country, 2021 - 2033 (USD Million)
  • Table 40 Asia Pacific Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 41 Asia Pacific Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 42 Japan Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 43 Japan Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 44 China Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 45 China Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 46 India Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 47 India Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 48 South Korea Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 49 South Korea Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 50 Australia Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 51 Australia Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 52 Singapore Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 53 Singapore Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 54 Thailand Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 55 Thailand Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 56 Latin America Kidney Function Tests Market, by Country, 2021 - 2033 (USD Million)
  • Table 57 Latin America Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 58 Latin America Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 59 Brazil Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 60 Brazil Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61 Argentina Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 62 Argentina Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 63 Middle East & Africa Kidney Function Tests Market, by Country, 2021 - 2033 (USD Million)
  • Table 64 Middle East & Africa Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 65 Middle East & Africa Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66 South Africa Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 67 South Africa Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 68 Saudi Arabia Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 69 Saudi Arabia Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70 UAE Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 71 UAE Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)
  • Table 72 Kuwait Kidney Function Tests Market, by Product, 2021 - 2033 (USD Million)
  • Table 73 Kuwait Kidney Function Tests Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Executives contacted
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Kidney function tests market estimation process
  • Fig. 10 Market snapshot
  • Fig. 11 Market segmentation and scope
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 Market drivers impact
  • Fig. 16 Reported causes of end-stage renal disease in the U.S.
  • Fig. 17 Percentage of U.S. adults aged 18 or older with CKD
  • Fig. 18 Market restraint relevance analysis (Current & future impact)
  • Fig. 19 Kidney function test market: product outlook and key takeaways
  • Fig. 20 Kidney function tests market: product movement analysis
  • Fig. 21 Clearance tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Blood tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Urine tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Dilution & concentration tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Other tests market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Kidney function test market: end use outlook and key takeaways
  • Fig. 27 Kidney function test market: end use movement analysis
  • Fig. 28 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Diagnostic laboratories market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Research laboratories and institutes market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Regional marketplace: key takeaways
  • Fig. 33 North America kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 U.S. kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Canada kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 Mexico kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Europe kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Germany kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 UK kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 France kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Italy kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 Spain kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Denmark kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Sweden kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Norway kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Asia Pacific kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Japan kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 China kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 India kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 South Korea kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Australia kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Thailand kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Singapore kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Latin America kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Brazil kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Argentina kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Middle East and Africa kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 South Africa kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 UAE kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Kuwait kidney function tests market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Market participant categorization
  • Fig. 63 Kidney function tests market share analysis, 2025
  • Fig. 64 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!